A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients

A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients

This item appears in the following Collection(s)

Available in accordance with the Publisher Policy. Please refer to the publisher's site for terms of use.

Search Repository


My Account

Statistics